Biotechnology companies are increasingly challenging traditional pharmaceutical
companies as the discoverers, developers and marketers of drugs. The biotechnology …

This book is aimed at providing a large audience, including practitioners, politicians and
decision-makers, with useful insights in relation to innovation and entrepreneurship in the …

Developing solutions for biopharma/medtech/digital medicine products and services
requires a cross-disciplinary team to engage a broad section of the healthcare ecosystem …

" Beginning in the 1970s, several scientific breakthroughs promised to transform the creation
of new medicines. As investors sought to capitalize on these Nobel Prize-winning …

Over the past three decades, the biotechnology industry has emerged as a vital and
dynamic source of new technologies for the pharmaceutical and agricultural chemical …

The processes of discovery, testing and distribution of new medicines have undergone
radical change in recent decades, from a focus on small molecule drugs to biomedicine and …

Biotech companies are generally faced with the paradoxes of simultaneously managing
growth and innovation, as well as addressing explorative and exploitative aspects of …

Executive Summary This report Health Biotechnology: Emerging Business Models and
Institutional Drivers addresses the future of firms and industry. In particular, the report …

The motivation (and personal ex-ante assumption) for this chapter comes from our combined
20 years' experience of research, consulting, operational positions, and ownership of more …

Early-Stage Biotech Companies: Strategies for Survival and Growth - PMC Back to Top Skip
to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …